Viewing StudyNCT06340243



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06340243
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-22

Brief Title: Risk Adapted Therapy of Hodgkin Lymphoma in Upper Egypt
Sponsor:
Organization: Assiut University

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: True
Target Duration: 2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 50
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
105393
Who Masked List: